Isofol Medical AB (publ) (FRA:5IU)

Revenue by Product

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Arfolitixorin	721.00K
Arfolitixorin Growth	-94.37%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Asia	721.00K
Asia Growth	-94.37%